Immunogenicity of a third dose of inactivated COVID-19 vaccine in people living with HIV-1, HBV, and tuberculosis during the Omicron variant epidemic: A cross-sectional study.

Yan, Yan; Davgadorj, Chantsalmaa; Lyu, Chunyan; Zhang, Shiliang; Qiu, Yuanwang

Yan, Yan; Davgadorj, Chantsalmaa; Lyu, Chunyan; Zhang, Shiliang; Qiu, Yuanwang.

Afiliación

Yan Y; Center of Clinical Laboratory, The Fifth People's Hospital of Wuxi, Affiliated Hospital of Jiangnan University, Wuxi, China; The International Joint Research Laboratory for Infection and Immunity (China-Germany), Jiangnan University, Wuxi, China; Hepatology Institute of Wuxi, The Fifth People's Hosp
Davgadorj C; Center of Clinical Laboratory, The Fifth People's Hospital of Wuxi, Affiliated Hospital of Jiangnan University, Wuxi, China; The International Joint Research Laboratory for Infection and Immunity (China-Germany), Jiangnan University, Wuxi, China.
Lyu C; Center of Clinical Laboratory, The Fifth People's Hospital of Wuxi, Affiliated Hospital of Jiangnan University, Wuxi, China.
Zhang S; Center of Clinical Laboratory, The Fifth People's Hospital of Wuxi, Affiliated Hospital of Jiangnan University, Wuxi, China. Electronic address: 136561987282@163.com.
Qiu Y; The International Joint Research Laboratory for Infection and Immunity (China-Germany), Jiangnan University, Wuxi, China; Hepatology Institute of Wuxi, The Fifth People's Hospital of Wuxi (Wuxi Infectious Disease Hospital), Affiliated Hospital of Jiangnan University, Wuxi, China. Electronic address:

J Infect ; 85(4): e109-e111, 2022 10.

Article en En | MEDLINE | ID: mdl-35803384

Asunto(s)

COVID-19; Seropositividad para VIH; VIH-1; Tuberculosis; Anticuerpos Antivirales; COVID-19/prevención & control; Vacunas contra la COVID-19; Estudios Transversales; Virus de la Hepatitis B; Humanos; Inmunogenicidad Vacunal; SARS-CoV-2; Tuberculosis/epidemiología; Tuberculosis/prevención & control

Palabras clave

Coronavirus disease 2019 (COVID-19); HBV; HIV-1; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Tuberculosis; Vaccine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 2_ODS3 / 3_ND / 4_TD Problema de salud: 1_doencas_nao_transmissiveis / 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 3_neglected_diseases / 3_tuberculosis / 4_pneumonia Asunto principal: Tuberculosis / VIH-1 / Seropositividad para VIH / COVID-19 Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Infect Año: 2022 Tipo del documento: Article

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google